The Scientist

» oncolytic viruses

Most Recent

image: Five Oncoviruses Debut On NIH Carcinogen List

Five Oncoviruses Debut On NIH Carcinogen List

By | November 7, 2016

Seven newly evaluated substances, including five oncoviruses, have been added to the US National Institutes of Health’s 14th Report on Carcinogens.

0 Comments

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

1 Comment

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2014

December 2014's selection of notable quotes

1 Comment

image: Contributors

Contributors

By | June 1, 2014

Meet some of the people featured in the June 2014 issue of The Scientist

0 Comments

image: Tactical Maneuvers

Tactical Maneuvers

By | June 1, 2014

Scientists are creating viruses that naturally home in on tumor cells while simultaneously boosting the body’s immune system to fight cancer.

2 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

image: Cancer-Fighting Virus

Cancer-Fighting Virus

By | June 13, 2012

A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham